Related Experiment Video
Updated: Sep 27, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Sternal Tuberculosis: Case Series of Two Cases
1Department of Orthopaedic, K B Bhabha Municipal General Hospital, Mumbai, Maharashtra, India.
Sternal tuberculosis (TB) is a rare condition, often presenting as chest swelling. This study highlights successful treatment with anti-tubercular drugs, emphasizing medication as the primary approach for this uncommon extrapulmonary TB manifestation.
Area of Science:
- Infectious Diseases
- Orthopedics
- Thoracic Surgery
Background:
- Extrapulmonary tuberculosis (TB) commonly affects the spine and joints, with sternal TB representing only 1% of musculoskeletal TB cases.
- Isolated sternal TB is rare and often presents atypically, posing diagnostic and management challenges.
- Early recognition and appropriate treatment are crucial for favorable outcomes in sternal TB.
Observation:
- Two cases of sternal TB are presented: a 52-year-old male with a 2-month history of chest wall swelling and a 19-year-old female with a 1-week history.
- Both patients presented with localized chest wall swelling and no constitutional symptoms.
- Initial presentations were managed conservatively with anti-tubercular drugs.
Findings:
- Both patients received a 12-month course of anti-tubercular medication.
- Complete resolution of sternal TB was achieved in both cases without surgical intervention.
- No prior medications were noted in either patient before presentation.
Implications:
- Anti-tubercular medication is the cornerstone of sternal TB treatment.
- Surgical intervention is typically reserved for refractory or complicated cases.
- Increased awareness of sternal TB presentations can improve diagnostic accuracy and patient management.
More Related Videos
10:19Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Published on: November 10, 2014
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumothorax-II
Clinical Manifestations: